Patients with nontuberculous mycobacteria: Comparison of updated and previous diagnostic criteria for lung disease

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 1, 2012, Pages 98-100

  Epson, Erin ^a   Cassidy, Maureen ^b   Marshall Olson, Angela ^c   Hedberg, Katrina ^b   Winthrop, Kevin L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON PUBLIC HEALTH DIVISION   (United States)

^c LEGACY HEALTH SYSTEM   (United States)

Author keywords

Diagnostic criteria; Lung disease; Nontuberculous mycobacteria

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACID FAST BACTERIUM; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BRONCHIECTASIS; EARLY DIAGNOSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; IMMUNOSUPPRESSIVE TREATMENT; LUNG BIOPSY; LUNG INFECTION; LUNG LAVAGE; LUNG NODULE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM XENOPEI; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PNEUMONIA, BACTERIAL; PREVALENCE;

EID: 84865295148     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.05.035     Document Type: Article

References (10)

1. Al-Mahruqi S.H., van-Ingen J., Al-Busaidy S., Boeree M.J., Al-Zadjali S., Patel A., et al. Clinical relevance of nontuberculous mycobacteria, Oman. Emerg Infect Dis Feb 2009, 15:292-294.
2. American Thoracic Society Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997, 156:S1-S25.
3. Chae D.R., Kim Y.I., Kee S.J., Kim Y.H., Chi S.Y., Ban H.J., et al. The impact of the 2007 ATS/IDSA diagnostic criteria for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease. Respiration 2011, 82:124-129.
4. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. American Thoracic Society/Infectious Disease Society of America: an official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
5. Lai C.C., Tan C.K., Chou C.H., Hsu H.L., Liao C.H., Huang Y.T., et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg Infect Dis Feb 2010, 16:294-296.
6. Marras T.K., Chedore P., Ying A.M., Jamieson F. Isolation prevalence of pulmonary nontuberculous mycobacterium in Ontario, 1997-2003. Thorax 2007, 62:661-666.
7. Prevots D.R., Shaw P.A., Strickland D., Jackson L.A., Raebel M.A., Blosky M.A., et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010, 182:970-976.
8. Thomson R.M. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis Oct 2010, 16:1576-1583. NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory.
9. van Ingen J., Boeree M.J., de Lang W.C., Dekhuijzen P.N., van Soolingen D. Letter to the Editor: impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection. Am J Respir Crit Care Med 2007, 176:418.
10. Winthrop K.L., McNelley E., Kendall B., Marshalel-Olson A., Morris C., Cassidy M., et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features; an emerging public health disease. Am J Respir Crit Care Med 2010, 182:977-982.